Peripheral artery disease (PAD) is a disease of blood vessels located outside the brain and heart. PAD occurs when plaque builds up in arteries that carry blood to the head, organs, and limbs. Plaque is made of fat, cholesterol, calcium, fibrous tissue, and other substances. PAD usually affects arteries in the legs, but it can also affect arteries that carry blood from heart to head, arms, kidneys, and stomach. The report provides dynamics and trends related to the global peripheral artery disease market. In addition, it presents estimations and forecast of the market. The study estimates revenue generated from sales of peripheral artery disease equipment. However, the report excludes revenue generated from post-sale services and service costs associated with the market.

Cancer immunotherapy has significantly advanced in the past few years, and PD-1/PD-L1 immunotherapy has emerged out as one of the most prominent therapies. Many clinical trials have proved their significance, and many are still underway to find other cancers which can be treated with this therapy.

The scope of the pain management drugs market report includes revenue generated by drugs that are used for treatment of various pain conditions such as cancer pain, post-operative pain, and chronic pain. The revenue of different classes of drugs such as opioids, antidepressants, and anesthetics has been included in the report.

Personal care ingredients are the raw materials which are used in the manufacturing of skin care products worldwide. These ingredients can be used in the skin care products as an anti-fungal agent, anti-ageing agent, skin conditioning agent, and others. They can also be classified as active and inactive ingredients. Active ingredients include anti-ageing agents, exfoliants, conditioning agents, and UV protecting agents whereas, inactive ingredients include surfactants, preservatives, colorants, and polymer ingredients. Rise in disposable incomes strengthened the purchasing power of consumers along with change in standard of living, which is expected to drive the growth of the personal care ingredients market during 2020-2027. In addition, increase in consumer awareness toward multi-purpose products fuel the growth of the market. However, side effects of chemical-based personal care products and stringent government regulations are the key factors hampering the growth of the market during the forecast period. Whereas, innovations in skin care products and rise in health awareness & increase in demand for personal care products are expected to create opportunities in the global personal care ingredients market during the analyzed timeframe.

The report provides market dynamics and trends related to the neurovascular devices market. Furthermore, it includes the study of revenue generated from sales of various types of neurovascular devices such as embolization devices, revascularization devices, thrombectomy devices, embolic protection devices, and accessory devices. In addition, the report is also segmented into disease pathology, which is divided into aneurysm, ateriovenous malformation, ischemic stroke, stenosis and others. This segmentation provides an idea about the use of various neurovascular devices in different types of neurovascular disorders. Furthermore, the report does not contain revenue generated from the sales of associated neurovascular services offered in the market.

The global neurostimulation devices market consists of various leading manufacturers, small-medium enterprises, and emerging start-ups. With the increasing demand for neuromodulation technologies, companies have the opportunity to expand in the market through different strategic approaches. Some of the strategies followed by the leading contributors are regulatory approvals, collaborations, partnerships, mergers, acquisitions, and product launches. In the past four years (January 2016-May 2020), the market witnessed approximately 22 funding activities, five mergers and acquisitions, 12 new offerings (product launches), 19 partnerships, alliances, and business expansions, and 69 regulatory approvals. Among the different key developments, regulatory approvals of the neurostimulation devices from different regulatory bodies, and funding activities are constituting the dominant contributor’s strategies.

Currently, the IVD industry is facing challenges such as stringent regulations, industry consolidation, new healthcare reforms, and ever-changing demographics. However, despite these challenges, the advent of new technologies and innovations has the potential to invigorate the growth of the IVD market. Molecular diagnostics, genomics, and next-generation sequencing are expected to be primary facilitators of this growth by providing new avenues for improved disease diagnosis, hence, redefining patient outcomes.

纵观2020年，由于新冠疫情影响，对全球经济都造成一定冲击，医药行业具有相对刚性需求的属性，逆周期和避险属性得以凸显，同时，部分产品受益于疫情拉动，上半年医药行业显著跑赢大盘、赢得超额收益。随着国内疫情得到有效控制以及复工复产的全面推进，国内投资热点频繁切换，医药板块经历了阶段性调整，前期较高的涨幅和估值有所消化。

2020 年前三季度，市场情绪受新冠疫情影响，一季度上证指数下跌10.3%，第二季度疫情防控效果良好，上证指数上涨10.0%，开工复产积极各行业股票普遍有所上涨，第三季度疫情影响持续消退，上证指数上涨7.8%。2020 年Q3 医药生物指数小幅上涨2.9%，单季度跑输上证指数。

事件：当地时间11月9日，辉瑞公布全球首个新冠疫苗ph3试验中期分析初步结果。独立数据监察委员会（DMC）对94名确诊病例进行的中期分析显示，辉瑞、BioNTech合作研发的BNT162b2在完成接种程序后7天的有效性超过90%。